Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 16,459 | 14,270 | 20,702 | 17,378 | 18,050 |
| Operating Income | -16,459 | -14,270 | -20,702 | -17,378 | -18,050 |
| Other Income | 1,054 | 1,545 | 1,362 | 1,387 | 1,339 |
| Pre-tax Income | -15,405 | -12,725 | -19,340 | -15,991 | -16,711 |
| Net Income Continuous | -15,405 | -12,725 | -19,340 | -15,991 | -16,711 |
| Net Income | $-15,405 | $-12,725 | $-19,340 | $-15,991 | $-16,711 |
| EPS Basic Total Ops | -4.87 | -3.80 | -6.15 | -5.09 | -6.00 |
| EPS Basic Continuous Ops | -4.87 | -3.86 | -6.15 | -5.09 | -5.94 |
| EPS Diluted Total Ops | -4.87 | -3.80 | -6.15 | -5.09 | -6.00 |
| EPS Diluted Continuous Ops | -4.87 | -3.86 | -6.15 | -5.09 | -5.94 |
| EPS Diluted Before Non-Recurring Items | -5.00 | -4.00 | -6.20 | -5.20 | N/A |
| EBITDA(a) | $-16,129 | $-13,916 | $-20,364 | $-16,878 | $-17,688 |